Full-Time

VP – Finance

Confirmed live in the last 24 hours

BigHat Biosciences

BigHat Biosciences

51-200 employees

Develops antibody therapies using machine learning

AI & Machine Learning
Biotechnology

Expert

San Mateo, CA, USA

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Data Analysis
PowerPoint/Keynote/Slides
Requirements
  • Proven work experience as a VP, Finance or equivalent
  • In-depth knowledge of financial benchmarking, accounting, audit and tax compliance and other regulatory matters
  • Possesses critical knowledge of federal and state tax laws as well as basic accounting issues
  • CPA preferred
  • Bachelor's degree required (finance/accounting, business, science, engineering)
  • 10+ years minimum of relevant work experience, preferably in one of the following areas: VP, Finance for biotechnology companies, management consulting, investment banking, or corporate development/operations roles within the biopharma industry
  • Expert in Excel, PowerPoint, and GoogleSuite; able to perform data analysis via Excel/Google Sheets to inform business & financial decision making
  • Proven track record of success facilitating progressive organizational change and development within a growing organization
  • Collaborative working style and demonstrated ability to build strong cross-functional relationships
  • Excellent verbal and written communication skills
  • Ability to identify and solve operational gaps & inefficiencies
  • Self-starter who enjoys working in a fast-paced and innovative high-growth environment
  • Inquisitive nature, strong attention to detail, diligence, and a great attitude
  • Results-oriented and able to roll up their sleeves to accomplish any task
  • Consistently delivers on commitments in a timely manner
Responsibilities
  • Lead BigHat’s Finance function, driving budgeting, forecasting, and long-term planning to ensure alignment with the Company’s strategic objectives
  • Work closely with founders and the executive team, serving as a key representative of the Finance department to internal stakeholders and to the Board of Directors
  • Oversee all accounting operations, including payables, receivables, payroll, and tax preparation, ensuring accuracy and compliance with regulatory standards
  • Evaluate, enhance, and implement tracking systems for revenue, expenses, and financial metrics, while establishing and maintaining robust policies, internal controls, and accounting procedures
  • Lead the annual budgeting process, providing clear guidance, accountability, and insights to align financial plans with operational and strategic goals
  • Develop, oversee, and manage the Company’s investment strategy to optimize resources and support long-term growth
  • Ensure compliance with all reporting requirements by preparing and managing timely and accurate annual, quarterly, and monthly reports
  • Support fundraising initiatives, corporate transactions, and audit processes, serving as a key financial representative during due diligence and negotiations
  • Partner with People Ops and Talent around compensation structure and execution

BigHat Biosciences focuses on developing antibody therapies using machine learning and synthetic biology. Their main product is the Milliner platform, which integrates a wet lab with advanced machine learning to rapidly design and engineer antibodies. This platform enables the synthesis, purification, and characterization of hundreds of antibodies each week, allowing for quicker development of effective treatments for challenging diseases like infections and cancers. Unlike many competitors, BigHat emphasizes a balance between high performance and a family-friendly work culture. The company's goal is to create safer and more effective therapies for patients while maintaining a supportive work environment.

Company Stage

Series B

Total Funding

$96.6M

Headquarters

San Carlos, California

Founded

2019

Growth & Insights
Headcount

6 month growth

10%

1 year growth

27%

2 year growth

92%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven protein engineering is crucial for personalized medicine, enhancing treatment effectiveness.
  • Collaborations with firms like Janssen and Merck accelerate drug discovery and development.
  • BigHat's stable growth and recent funding support its expansion and product development.

What critics are saying

  • Increased competition in the ADC space could overshadow BigHat's collaborations.
  • Over-reliance on large pharmaceutical collaborations may limit BigHat's strategic autonomy.
  • Rapid team expansion could lead to integration challenges and cultural dilution.

What makes BigHat Biosciences unique

  • BigHat's Milliner platform integrates AI with synthetic biology for rapid antibody development.
  • The company focuses on difficult-to-treat diseases, enhancing treatment options for complex conditions.
  • BigHat's strategic collaborations with major firms like Janssen and Merck boost its innovation capabilities.

Help us improve and share your feedback! Did you find this helpful?